- Home
- MGRX vs BFRI Comparison
MGRX vs BFRI Comparison
Compare MGRX & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- BFRI
- Stock Information
- Founded
- MGRX 2021
- BFRI 1997
- Country
- MGRX United States
- BFRI United States
- Employees
- MGRX N/A
- BFRI N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- MGRX Technology
- BFRI Health Care
- Exchange
- MGRX Nasdaq
- BFRI Nasdaq
- Market Cap
- MGRX 8.1M
- BFRI 7.5M
- IPO Year
- MGRX 2023
- BFRI 2021
- Fundamental
- Price
- MGRX $1.50
- BFRI $0.88
- Analyst Decision
- MGRX
- BFRI Strong Buy
- Analyst Count
- MGRX 0
- BFRI 1
- Target Price
- MGRX N/A
- BFRI $2.75
- AVG Volume (30 Days)
- MGRX 160.2K
- BFRI 218.4K
- Earning Date
- MGRX 08-13-2025
- BFRI 08-13-2025
- Dividend Yield
- MGRX N/A
- BFRI N/A
- EPS Growth
- MGRX N/A
- BFRI N/A
- EPS
- MGRX N/A
- BFRI N/A
- Revenue
- MGRX $511,084.00
- BFRI $37,997,000.00
- Revenue This Year
- MGRX N/A
- BFRI $11.75
- Revenue Next Year
- MGRX N/A
- BFRI $17.09
- P/E Ratio
- MGRX N/A
- BFRI N/A
- Revenue Growth
- MGRX N/A
- BFRI 14.28
- 52 Week Low
- MGRX $1.32
- BFRI $0.54
- 52 Week High
- MGRX $7.66
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- MGRX 45.69
- BFRI 72.09
- Support Level
- MGRX $1.41
- BFRI $0.66
- Resistance Level
- MGRX $2.04
- BFRI $0.91
- Average True Range (ATR)
- MGRX 0.17
- BFRI 0.07
- MACD
- MGRX -0.02
- BFRI 0.02
- Stochastic Oscillator
- MGRX 33.43
- BFRI 80.56
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.